FiercePharmaAsia—Sinopharm, Sinovac COVID vaccines; Takeda’s warning letter, $2B pipeline cull
China’s Sinopharm and Sinovac reported positive midstage clinical results for their inactivated COVID-19 vaccines, just as Clover Biopharmaceuticals entered the clinic with its subunit vaccine with help from adjuvants by GlaxoSmithKline and Dynavax. A Takeda plant in Japan was slapped with an FDA warning letter, and the company is sending off seven neuroscience assets to Neurocrine… Read More »